CH Term (R4)
3.5.0-ci-build - ci-build
CH Term (R4)
3.5.0-ci-build - ci-build
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.5.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Active as of 2026-07-08 |
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- <http://hl7.org/fhir/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm> a fhir:ConceptMap ; fhir:nodeRole fhir:treeRoot ; fhir:Resource.id [ fhir:value "ch-vacd-immunoglobulin-targetdiseases-cm"] ; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ] ; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm</b></p><a name=\"ch-vacd-immunoglobulin-targetdiseases-cm\"> </a><a name=\"hcch-vacd-immunoglobulin-targetdiseases-cm\"> </a><p>Mapping from <a href=\"ValueSet-ch-vacd-swissmedic-immunoglobulin-vs.html\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href=\"ValueSet-ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs.html\">CH VACD Target disease and illnesses undergone for immunization</a></p><br/><p>Mapping from <a href=\"CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a> to <a href=\"http://hl7.org/fhir/R4/codesystem-snomedct.html\">SNOMED CT (all versions)</a></p><table class=\"grid\"><tr><td colspan=\"2\"><b>Source Concept Details</b></td><td><b>Relationship</b></td><td colspan=\"2\"><b>Target Concept Details</b></td></tr><tr><td colspan=\"2\"><b>Codes</b> from <a href=\"CodeSystem-ch-vacd-swissmedic-immunoglobulin-cs.html\" title=\"http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs\">CH VACD Swissmedic Authorized Immunoglobulin Codes</a></td><td/><td colspan=\"2\"><b>Codes</b> from <a href=\"http://hl7.org/fhir/R4/codesystem-snomedct.html\" title=\"http://snomed.info/sct\">SNOMED CT (all versions)</a></td></tr><tr><td style=\"border-right-width: 0px\">00687-01</td><td style=\"border-left-width: 0px\">Berirab 2 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14168008</td><td style=\"border-left-width: 0px\">Rabies (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00687-02</td><td style=\"border-left-width: 0px\">Berirab 5 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14168008</td><td style=\"border-left-width: 0px\">Rabies (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">69039-02</td><td style=\"border-left-width: 0px\">Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">69039-01</td><td style=\"border-left-width: 0px\">Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">68222-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Cutaquig 165 mg/ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">65992-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Cuvitru 200 mg/ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00506-02</td><td style=\"border-left-width: 0px\">Cytotect CP Biotest, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">28944009</td><td style=\"border-left-width: 0px\">Infection caused by Cytomegalovirus (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">00701-02</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Gammanorm, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">16318001000119107</td><td style=\"border-left-width: 0px\">Hypogammaglobulinemia due to multiple myeloma (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00668-01</td><td style=\"border-left-width: 0px\">Gamunex 10%, solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">14189004</td><td style=\"border-left-width: 0px\">Measles (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00488-02</td><td style=\"border-left-width: 0px\">Hepatect CP, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00674-01</td><td style=\"border-left-width: 0px\">Hepatitis-B-Immunglobulin Behring, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66410-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">61547-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Hizentra, Injektionslösung zur s.c. Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66684-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">58157-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Ig Vena Kedrion 50 g/I, solution pour infusion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">62913-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Intratect 10%, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">57676-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Intratect 5%, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-03</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 10g/100ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-04</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 20g/200ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 2g/20ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">66332-02</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Iqymune 5g/50ml, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">57469-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Kiovig, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">60323-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Octagam 10 %, Lösung zur intravenösen Anwendung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-bottom-style: none\">58314-01</td><td style=\"border-left-width: 0px; border-bottom-style: none\">Privigen, Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">58606001</td><td style=\"border-left-width: 0px\">Primary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px; border-top-style: none\"/><td style=\"border-top-style: none; border-left-width: 0px\"/><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">33286000</td><td style=\"border-left-width: 0px\">Secondary immune deficiency disorder (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">53609-02</td><td style=\"border-left-width: 0px\">Rhophylac 300, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">165746003</td><td style=\"border-left-width: 0px\">RhD negative (finding)</td></tr><tr><td style=\"border-right-width: 0px\">65695-02</td><td style=\"border-left-width: 0px\">Synagis 100 mg/1 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">65695-01</td><td style=\"border-left-width: 0px\">Synagis 50 mg/0.5 ml, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">55735004</td><td style=\"border-left-width: 0px\">Respiratory syncytial virus infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">00673-02</td><td style=\"border-left-width: 0px\">Tetagam P, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">76902006</td><td style=\"border-left-width: 0px\">Tetanus (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59374-01</td><td style=\"border-left-width: 0px\">Uman Big 180 UI/1 ml, solution pour injection intramusculaire</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59374-02</td><td style=\"border-left-width: 0px\">Uman Big 540 UI/3 ml, solution pour injection intramusculaire</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59451-01</td><td style=\"border-left-width: 0px\">Varitect CP, Lösung zur intravenösen Injektion</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">38907003</td><td style=\"border-left-width: 0px\">Varicella (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59373-02</td><td style=\"border-left-width: 0px\">Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">59373-01</td><td style=\"border-left-width: 0px\">Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">68471-01</td><td style=\"border-left-width: 0px\">Xevudy, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">840539006</td><td style=\"border-left-width: 0px\">Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">66344-01</td><td style=\"border-left-width: 0px\">Zinplava, Konzentrat zur Herstellung einer Infusionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">56688005</td><td style=\"border-left-width: 0px\">Clostridial infection (disorder)</td></tr><tr><td style=\"border-right-width: 0px\">61639-01</td><td style=\"border-left-width: 0px\">Zutectra, Injektionslösung</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#relatedto\" title=\"relatedto\">is related to</a></td><td style=\"border-right-width: 0px\">66071002</td><td style=\"border-left-width: 0px\">Viral hepatitis type B (disorder)</td></tr></table></div>" ] ; fhir:ConceptMap.url [ fhir:value "http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm"] ; fhir:ConceptMap.version [ fhir:value "3.5.0-ci-build"] ; fhir:ConceptMap.name [ fhir:value "ImmunGlobulineToTargetDiseaseMapping"] ; fhir:ConceptMap.title [ fhir:value "ImmunGlobuline To TargetDisease Mapping"] ; fhir:ConceptMap.status [ fhir:value "active"] ; fhir:ConceptMap.experimental [ fhir:value "false"^^xsd:boolean] ; fhir:ConceptMap.date [ fhir:value "2026-07-08T07:34:33+00:00"^^xsd:dateTime] ; fhir:ConceptMap.publisher [ fhir:value "HL7 Switzerland"] ; fhir:ConceptMap.contact [ fhir:index 0 ; fhir:ContactDetail.name [ fhir:value "HL7 Switzerland" ] ; fhir:ContactDetail.telecom [ fhir:index 0 ; fhir:ContactPoint.system [ fhir:value "url" ] ; fhir:ContactPoint.value [ fhir:value "https://www.hl7.ch/" ] ] ], [ fhir:index 1 ; fhir:ContactDetail.name [ fhir:value "HL7 Switzerland" ] ; fhir:ContactDetail.telecom [ fhir:index 0 ; fhir:ContactPoint.system [ fhir:value "url" ] ; fhir:ContactPoint.value [ fhir:value "https://www.hl7.ch/" ] ; fhir:ContactPoint.use [ fhir:value "work" ] ] ] ; fhir:ConceptMap.description [ fhir:value "Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets"] ; fhir:ConceptMap.jurisdiction [ fhir:index 0 ; fhir:CodeableConcept.coding [ fhir:index 0 ; fhir:Coding.system [ fhir:value "urn:iso:std:iso:3166" ] ; fhir:Coding.code [ fhir:value "CH" ] ] ] ; fhir:ConceptMap.copyright [ fhir:value "This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org."] ; fhir:ConceptMap.sourceUri [ fhir:value "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs"] ; fhir:ConceptMap.targetUri [ fhir:value "http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs"] ; fhir:ConceptMap.group [ fhir:index 0 ; fhir:ConceptMap.group.source [ fhir:value "http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs" ] ; fhir:ConceptMap.group.target [ fhir:value "http://snomed.info/sct" ] ; fhir:ConceptMap.group.element [ fhir:index 0 ; fhir:ConceptMap.group.element.code [ fhir:value "00687-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Berirab 2 ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "14168008" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Rabies (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.code [ fhir:value "00687-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Berirab 5 ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "14168008" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Rabies (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 2 ; fhir:ConceptMap.group.element.code [ fhir:value "69039-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "55735004" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Respiratory syncytial virus infection (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 3 ; fhir:ConceptMap.group.element.code [ fhir:value "69039-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "55735004" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Respiratory syncytial virus infection (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 4 ; fhir:ConceptMap.group.element.code [ fhir:value "68222-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Cutaquig 165 mg/ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 5 ; fhir:ConceptMap.group.element.code [ fhir:value "65992-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Cuvitru 200 mg/ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 6 ; fhir:ConceptMap.group.element.code [ fhir:value "00506-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Cytotect CP Biotest, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "28944009" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Infection caused by Cytomegalovirus (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 7 ; fhir:ConceptMap.group.element.code [ fhir:value "00701-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Gammanorm, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "16318001000119107" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Hypogammaglobulinemia due to multiple myeloma (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 8 ; fhir:ConceptMap.group.element.code [ fhir:value "00668-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Gamunex 10%, solution pour injection intraveineuse" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "14189004" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Measles (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 9 ; fhir:ConceptMap.group.element.code [ fhir:value "00488-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Hepatect CP, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 10 ; fhir:ConceptMap.group.element.code [ fhir:value "00674-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Hepatitis-B-Immunglobulin Behring, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 11 ; fhir:ConceptMap.group.element.code [ fhir:value "66410-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 12 ; fhir:ConceptMap.group.element.code [ fhir:value "61547-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Hizentra, Injektionslösung zur s.c. Anwendung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 13 ; fhir:ConceptMap.group.element.code [ fhir:value "66684-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 14 ; fhir:ConceptMap.group.element.code [ fhir:value "58157-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Ig Vena Kedrion 50 g/I, solution pour infusion" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 15 ; fhir:ConceptMap.group.element.code [ fhir:value "62913-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Intratect 10%, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 16 ; fhir:ConceptMap.group.element.code [ fhir:value "57676-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Intratect 5%, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 17 ; fhir:ConceptMap.group.element.code [ fhir:value "66332-03" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Iqymune 10g/100ml, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 18 ; fhir:ConceptMap.group.element.code [ fhir:value "66332-04" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Iqymune 20g/200ml, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 19 ; fhir:ConceptMap.group.element.code [ fhir:value "66332-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Iqymune 2g/20ml, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 20 ; fhir:ConceptMap.group.element.code [ fhir:value "66332-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Iqymune 5g/50ml, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 21 ; fhir:ConceptMap.group.element.code [ fhir:value "57469-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Kiovig, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 22 ; fhir:ConceptMap.group.element.code [ fhir:value "60323-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Octagam 10 %, Lösung zur intravenösen Anwendung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 23 ; fhir:ConceptMap.group.element.code [ fhir:value "58314-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Privigen, Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "58606001" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Primary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ], [ fhir:index 1 ; fhir:ConceptMap.group.element.target.code [ fhir:value "33286000" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Secondary immune deficiency disorder (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 24 ; fhir:ConceptMap.group.element.code [ fhir:value "53609-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Rhophylac 300, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "165746003" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "RhD negative (finding)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 25 ; fhir:ConceptMap.group.element.code [ fhir:value "65695-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Synagis 100 mg/1 ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "55735004" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Respiratory syncytial virus infection (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 26 ; fhir:ConceptMap.group.element.code [ fhir:value "65695-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Synagis 50 mg/0.5 ml, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "55735004" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Respiratory syncytial virus infection (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 27 ; fhir:ConceptMap.group.element.code [ fhir:value "00673-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Tetagam P, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "76902006" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Tetanus (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 28 ; fhir:ConceptMap.group.element.code [ fhir:value "59374-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Uman Big 180 UI/1 ml, solution pour injection intramusculaire" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 29 ; fhir:ConceptMap.group.element.code [ fhir:value "59374-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Uman Big 540 UI/3 ml, solution pour injection intramusculaire" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 30 ; fhir:ConceptMap.group.element.code [ fhir:value "59451-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Varitect CP, Lösung zur intravenösen Injektion" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "38907003" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Varicella (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 31 ; fhir:ConceptMap.group.element.code [ fhir:value "59373-02" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 32 ; fhir:ConceptMap.group.element.code [ fhir:value "59373-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 33 ; fhir:ConceptMap.group.element.code [ fhir:value "68471-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Xevudy, Konzentrat zur Herstellung einer Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "840539006" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 34 ; fhir:ConceptMap.group.element.code [ fhir:value "66344-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Zinplava, Konzentrat zur Herstellung einer Infusionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "56688005" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Clostridial infection (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ], [ fhir:index 35 ; fhir:ConceptMap.group.element.code [ fhir:value "61639-01" ] ; fhir:ConceptMap.group.element.display [ fhir:value "Zutectra, Injektionslösung" ] ; fhir:ConceptMap.group.element.target [ fhir:index 0 ; fhir:ConceptMap.group.element.target.code [ fhir:value "66071002" ] ; fhir:ConceptMap.group.element.target.display [ fhir:value "Viral hepatitis type B (disorder)" ] ; fhir:ConceptMap.group.element.target.equivalence [ fhir:value "relatedto" ] ] ] ] . # - ontology header ------------------------------------------------------------ <http://hl7.org/fhir/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm.ttl> a owl:Ontology ; owl:imports fhir:fhir.ttl ; owl:versionIRI <http://build.fhir.org/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm.ttl> .
IG © 2019+ HL7 Switzerland. Package ch.fhir.ig.ch-term#3.5.0-ci-build based on FHIR 4.0.1. Generated 2026-07-08
Links: Table of Contents |
QA Report
| Propose a change